- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Dihydroergotamine, Ergot-containing drugs, Isocarboxazid, MAO inhibitors, Methysergide, Naratriptan, Phenelzine, Propranolol, Sibutramine, SSRIs, St John's Wort, Sumatriptan, Tranylcypromine, Zolmitriptan
- See adverse reactions attributed to class:
Triptan
Please login to view the rest of this drug profile.
Page last updated 07/31/2023